Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00588991
What this trial is testing

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT04905810
What this trial is testing

Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

Who this might be right for
Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia
Brian Jonas 20
Not applicableUnknownNCT02623413
What this trial is testing

Cohort Study of German Hematological / Oncological Wards to Assess the Effect of Contact Precautions on Nosocomial Colonization With Vancomycin Resistant Enterococci

Who this might be right for
Vancomycin (Glycopeptide) Resistant Enterococcus (VRE)Cancer
University of Cologne 950
Not applicableStudy completedNCT03575767
What this trial is testing

Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT

Who this might be right for
Hematologic NeoplasmsHematopoietic Stem Cell TransplantationGraft Vs Host Disease+1 more
Affiliated Hospital to Academy of Military Medical Sciences 30
Not applicableStudy completedNCT03806712
What this trial is testing

Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)

Who this might be right for
Platelet TransfusionHematological MalignancyPalliative Care
Centre Hospitalier Universitaire de Besancon 45
Early research (Phase 1)WithdrawnNCT00666081
What this trial is testing

Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Cancer
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00003619
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Drexel University College of Medicine
Early research (Phase 1)Looking for participantsNCT06558253
What this trial is testing

The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT

Who this might be right for
Hematopoietic Recovery
Anhui Provincial Hospital 12
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Looking for participantsNCT06938867
What this trial is testing

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

Who this might be right for
E Coli InfectionsAllogenic Transplant Patients
SNIPR Biome Aps. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439201
What this trial is testing

Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+2 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00884312
What this trial is testing

Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols

Who this might be right for
Multiple MyelomaSolid Tumors
Amgen 101
Early research (Phase 1)Not Yet RecruitingNCT05995028
What this trial is testing

Universal 4SCAR7U Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Not applicableLooking for participantsNCT05956457
What this trial is testing

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapsed Hematologic Malignancy
Pack Health 100
Not applicableEnded earlyNCT03080792
What this trial is testing

Pre-Exercise for Allogeneic Stem Cell Transplant Patients

Who this might be right for
Cancer, Hematological
University Hospital Heidelberg 14
Early research (Phase 1)Ended earlyNCT03588936
What this trial is testing

Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant

Who this might be right for
Acute LeukemiaChronic LeukemiaLymphoma+1 more
Medical College of Wisconsin 2
Early research (Phase 1)Not Yet RecruitingNCT07485504
What this trial is testing

Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Relapsed or Refractory Hematologic Malignancies
Tcelltech Inc. 15
Early research (Phase 1)Active Not RecruitingNCT03913949
What this trial is testing

Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaNon Hodgkin Lymphoma
Ascentage Pharma Group Inc. 74
Not applicableUnknownNCT02056548
What this trial is testing

Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy

Who this might be right for
LymphomaChronic Hepatitis B
Seoul St. Mary's Hospital 126
Not applicableLooking for participantsNCT05306509
What this trial is testing

Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology

Who this might be right for
Solid TumorHematological Malignancies
Children's Hospital of Fudan University 120
Next Page